Morphis, Michaella http://orcid.org/0000-0002-3100-1618
van Staden, Johan A.
du Raan, Hanlie
Ljungberg, Michael
Sjögreen Gleisner, Katarina
Funding for this research was provided by:
South African Agency for Science and Technology Advancement (160811184621)
South African Medical Research Council (SAMRC-RFA-UFSP-01-2013/HARD)
Article History
Received: 16 January 2024
Accepted: 7 June 2024
First Online: 20 June 2024
Declarations
:
: This study was approved by the Health Sciences Research Ethics Committee at the University of the Free State, (UFS-HSD2019/2135/2502). The HSREC functions in compliance with, but not limited to, the following documents and guidelines: The SA National Health Act. No. 61 of 2003; Ethics in Health Research: Principles, Structures and Processes (2015); SA GCP(2006); Declaration of Helsinki; The Belmont Report; The US Office of Human Research Protections 45 CFR 461 (for non-exempt research with human participants conducted or supported by the US Department of Health and Human Services-(HHS), 21 CFR 50, 21 CFR 56; CIOMS; ICH-GCP-E6 Sections 1–4; The International Conference on Harmonization and Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH Tripartite), Guidelines of the SA Medicines Control Council as well as Laws and Regulations with regard to the Control of Medicines, Constitution of the HSREC of the Faculty of Health Sciences.
: Not applicable.
: The authors declare that they have no competing interests.